Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.0095 | 0.0095 |
Toxoplasma gondii | ABC1 family protein | 0.004 | 0.0095 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0.0095 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.004 | 0.0095 | 0.0095 |
Onchocerca volvulus | 0.004 | 0.0095 | 0.5 | |
Onchocerca volvulus | 0.004 | 0.0095 | 0.5 | |
Entamoeba histolytica | Pten 3-phosphoinositide phosphatase, putative | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0.0095 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.004 | 0.0095 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.0095 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.004 | 0.0095 | 0.5 |
Brugia malayi | beta-lactamase | 0.004 | 0.0095 | 0.0095 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Echinococcus granulosus | cyclin g associated kinase | 0.0367 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase, putative | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0.0095 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.004 | 0.0095 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0.0095 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.004 | 0.0095 | 0.0095 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Mycobacterium ulcerans | hypothetical protein | 0.004 | 0.0095 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.004 | 0.0095 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.0095 | 0.0095 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.004 | 0.0095 | 0.0095 |
Onchocerca volvulus | 0.004 | 0.0095 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Echinococcus multilocularis | cyclin g associated kinase | 0.0367 | 1 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.004 | 0.0095 | 0.0095 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0095 | 0.0095 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0253 | 0.6561 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0367 | 1 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.004 | 0.0095 | 0.0095 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.004 | 0.0095 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.004 | 0.0095 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.0095 | 0.0095 |
Leishmania major | hypothetical protein, conserved | 0.004 | 0.0095 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.0095 | 1 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.0095 | 0.0095 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.004 | 0.0095 | 1 |
Loa Loa (eye worm) | NAK/GAK protein kinase | 0.0367 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0329 | 0.8847 | 0.8847 |
Trichomonas vaginalis | esterase, putative | 0.004 | 0.0095 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0.0095 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.004 | 0.0095 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 100 uM | Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay | ChEMBL. | 23644219 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.